Association of P2X7 receptor gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population

Neuroscience Letters

Volumn 546, Issue , 2013, Pages 42-45

  Liu, Hongxin ^a   Han, Xun ^a   Li, Yongsheng ^a   Zou, Haiqiang ^b   Xie, Anmu ^a  

^a QINGDAO UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

P2X7 receptor; Parkinson's disease (PD); Single nucleotide polymorphisms (SNPs)

Indexed keywords

GENOMIC DNA; PURINERGIC P2X7 RECEPTOR; RECEPTOR;

ADULT; ARTICLE; CHINESE; CHROMOSOME POSITIONING; CONTROLLED STUDY; DNA POLYMORPHISM; DNA PURIFICATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RECEPTORS, PURINERGIC P2X7; RISK FACTORS;

EID: 84878906504     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.04.049     Document Type: Article

References (25)

1. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2001, 2:734-744.
2. Alloisio S., Cervetto C., Passalacqua M., Barbieri R., Maura G., Nobile M., Marcoli M. Functional evidence for presynaptic P2X7 receptors in adult rat cerebrocortical nerve terminals. FEBS Lett. 2008, 582:3948-3953.
3. Alves G., Forsaa E.B., Pedersen K.F., Dreetz G.M., Larsen J.P. Epidemiology of Parkinson's disease. J. Neurol. 2008, 255(Suppl. 5):18-32.
4. Anderson C.M., Nedergaard M. Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons. Trends Neurosci. 2006, 29:257-262.
5. Bartels A.L., Leenders K.L. Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov. Disord. 2007, 22:1852-1856.
6. Choi H.B., Ryu J.K., Kim S.U., McLarnon J.G. Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain. J. Neurosci. 2007, 27:4957-4968.
7. Daniel S.E., Lees A.J. Parkinson's Disease Society Brain Bank, London: overview and research. J. Neural Transm. Suppl. 1993, 39:165-172.
8. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
9. Denlinger L.C., Coursin D.B., Schell K., Angelini G., Green D.N., Guadarrama A.G., Halsey J., Prabhu U., Hogan K.J., Bertics P.J. Human P2X7 pore function predicts allele linkage disequilibrium. Clin. Chem. 2006, 52:995-1004.
10. Ferrari D., Pizzirani C., Adinolfi E., Lemoli R.M., Curti A., Idzko M., Panther E., Di Virgilio F. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 2006, 176:3877-3883.
11. Fuller S.J., Stokes L., Skarratt K.K., Gu B.J., Wiley J.S. Genetics of the P2X7 receptor and human disease. Purinergic Signal 2009, 5:257-262.
12. Gao H.M., Kotzbauer P.T., Uryu K., Leight S., Trojanowski J.Q., Lee V.M. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J. Neurosci. 2008, 28:7687-7698.
13. Gu B.J., Zhang W., Worthington R.A., Sluyter R., Dao-Ung P., Petrou S., Barden J.A., Wiley J.S. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J. Biol. Chem. 2001, 276:11135-11142.
14. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
15. Jellinger K.A. The pathology of Parkinson's disease. Adv. Neurol. 2001, 86:55-72.
16. Jun D.J., Kim J., Jung S.Y., Song R., Noh J.H., Park Y.S., Ryu S.H., Kim J.H., Kong Y.Y., Chung J.M., Kim K.T. Extracellular ATP mediates necrotic cell swelling in SN4741 dopaminergic neurons through P2X7 receptors. J. Biol. Chem. 2007, 282:37350-37358.
17. Lee K.H., Park S.S., Kim I., Kim J.H., Ra E.K., Yoon S.S., Hong Y.C., Park S., Kim B.K. P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Haematologica 2007, 92(May (5)):651-657.
18. Liu B., Xie J. Increased dopamine release in vivo by estradiol benzoate from the central amygdaloid nucleus of Parkinson's disease model rats. J. Neurochem. 2004, 90:654-658.
19. Marcellino D., Suarez-Boomgaard D., Sanchez-Reina M.D., Aguirre J.A., Yoshitake T., Yoshitake S., Hagman B., Kehr J., Agnati L.F., Fuxe K., Rivera A. On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079. J. Neural Transm. 2010, 117:681-687.
20. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 2002, 82:1013-1067.
21. Shemon A.N., Sluyter R., Fernando S.L., Clarke A.L., Dao-Ung L.P., Skarratt K.K., Saunders B.M., Tan K.S., Gu B.J., Fuller S.J., Britton W.J., Petrou S., Wiley J.S. A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J. Biol. Chem. 2006, 281:2079-2086.
22. Sluyter R., Shemon A.N., Wiley J.S. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J. Immunol. 2004, 172:3399-3405.
23. Son J.H., Chun H.S., Joh T.H., Cho S., Conti B., Lee J.W. Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J. Neurosci. 1999, 19:10-20.
24. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., Langston J.W. Parkinson disease in twins: an etiologic study. JAMA 1999, 281:341-346.
25. Wiley J.S., Dao-Ung L.P., Li C., Shemon A.N., Gu B.J., Smart M.L., Fuller S.J., Barden J.A., Petrou S., Sluyter R. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7receptor. J. Biol. Chem. 2003, 278(May (19)):17108-17113.